Results 301 to 310 of about 166,249 (334)
Some of the next articles are maybe not open access.
Infectious Diseases in Clinical Practice, 2021
Background Carbapenem-resistant Enterobacteriaceae (CRE) is currently an emerging global public health problem and has significant negative impacts in many countries. This study aimed to identify risk factors associated with the mortality and readmission of CRE- and carbapenem-susceptible Enterobacteriaceae (CSE)–infected ...
Suluck Soontaros +4 more
openaire +1 more source
Background Carbapenem-resistant Enterobacteriaceae (CRE) is currently an emerging global public health problem and has significant negative impacts in many countries. This study aimed to identify risk factors associated with the mortality and readmission of CRE- and carbapenem-susceptible Enterobacteriaceae (CSE)–infected ...
Suluck Soontaros +4 more
openaire +1 more source
Enterobacteriaceae populations during experimental Salmonella infection in pigs
Veterinary Microbiology, 2010Salmonella infection might affect other intestinal Enterobacteriaceae populations and possible correlations between single Enterobacteriaceae populations would help to predict subclinical Salmonella infections in pigs. In one experimental setup, weaned piglets (n=40) were infected with Salmonella and sacrificed at 3h, 24h, 72 h or 28 days post ...
Sebastian, Guenther +7 more
openaire +2 more sources
A serologic response in human infection with Enterobacteriaceae
The American Journal of the Medical Sciences, 1977Sera from patients infected with Escherichia coli, Proteus, Klebsiella, and Serratia were studied for precipitins to ultrasonic extracts of these organisms in gel-diffusion plates. Sera from 66 per cent of these patients contained precipitins when initially tested. Twenty-four per cent of sera tested in the first week after onset of infection contained
J C, Crowder +3 more
openaire +2 more sources
ESBL-producing Enterobacteriaceae: controlling the spread of infection
British Journal of Nursing, 2007Extended spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae were first reported in Europe in the 1980s and have since become a worldwide problem. This has resulted in increased morbidity, mortality and cost in treating the infections they cause (Paterson et al, 2001; Bisson et al, 2002). In the UK the prevalence of ESBL rose from 5.4% in 1997 to
openaire +2 more sources
Disparity in infection control practices for multidrug-resistant Enterobacteriaceae
American Journal of Infection Control, 2012There is a lack of empiric evidence regarding the optimal approach to controlling the transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE). In this context, we expect that infection control practices for these organisms vary widely between hospitals.A survey examining ...
Christopher, Lowe +3 more
openaire +2 more sources
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections
Expert Review of Anti-infective Therapy, 2019Introduction: The epidemiology of carbapenem-resistant Enterobacterales (CRE) is increasingly worldwide. Production of carbapenemases is the most common and efficient mechanism of carbapenem resistance, and could theoretically be overcome by optimizing the pharmacokinetic/pharmacodynamic (PK/PD) behavior of meropenem.
Pascale R. +4 more
openaire +3 more sources
Risk of resistant infections with Enterobacteriaceae in hospitalized neonates
The Pediatric Infectious Disease Journal, 2002To determine the risk factors associated with progression from colonization to infection with health care-associated antimicrobial-nonsusceptible Enterobacteriaceae (ANE) in critically ill neonates.During a 3-year period (1998 to 2000), surveillance rectal cultures were performed on neonates admitted to our Level III neonatal intensive care unit after ...
Nalini, Singh +6 more
openaire +2 more sources
Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
Canadian Medical Association journal, 1975The incidence of trimethoprim-resistant Enterobacteriaceae has not increased since the introduction of the combination trimethoprim-sulfamethoxazole (TMP-SMX) into the clinical use at our centre in 1973. Using the minimum inhibitory concentration (MIC) as the index of trimethoprim resistance, this ranged from 1.6 to 800 mug/ml; for the majority of ...
C K, Wong +3 more
openaire +1 more source
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Ca-A Cancer Journal for Clinicians, 2021Amila K Nanayakkara +2 more
exaly